[HTML] springer.comFull View

[HTML][HTML] Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for immunotherapy of …, 2019 - Springer
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …
被引用次数：89 相关文章

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

S Pabla, JM Conroy, MK Nesline… - … for immunotherapy of …, 2019 - escholarship.org
BackgroundResistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline… - Journal for …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for ImmunoTherapy of …, 2019 - infona.pl
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for Immunotherapy of …, 2019 - europepmc.org
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for ImmunoTherapy of …, 2019 - go.gale.com
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …
[HTML] bmj.com

[HTML][HTML] Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for ImmunoTherapy of …, 2019 - jitc.bmj.com
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …
[HTML] biomedcentral.com

[HTML][HTML] Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline… - Journal for …, 2019 - jitc.biomedcentral.com
Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …
[HTML] nih.gov

[HTML][HTML] Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy, MK Nesline, ST Glenn… - … for Immunotherapy of …, 2019 - ncbi.nlm.nih.gov
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

S Pabla, JM Conroy… - Journal for …, 2019 - utsouthwestern.elsevierpure.com
Background: Resistance to immune checkpoint inhibitors (ICIs) has been linked to local
immunosuppression independent of major ICI targets (eg, PD-1). Clinical experience with …